Onsi Douglas E.'s most recent trade in Cypherpunk Technologies Inc. was a trade of 2,600,000 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 2,600,000 | 2,600,000 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 2,136 | 0 (0%) | 0% | 0 | Common Stock | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Other type of transaction at price $ 0.00 per share. | 23 Dec 2025 | 712 | 106,858 (0%) | 0% | 0 | Common Stock | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Sale of securities on an exchange or to another person at price $ 3.14 per share. | 17 Nov 2025 | 414,479 | 2,136 (0%) | 1% | 3.1 | 1,301,464 | Common Stock |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Sale of securities on an exchange or to another person at price $ 3.14 per share. | 17 Nov 2025 | 261,840 | 416,616 (1%) | 1% | 3.1 | 822,178 | Common Stock |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2025 | 2,087,287 | 2,087,287 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 32,500 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 32,500 | 106,146 (0%) | 0% | - | Common Stock | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | 13 Nov 2024 | 2,136 | 0 | - | - | Warrant (Right to Buy) | ||
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.&Sec. | 13 Nov 2024 | 2,136 | 678,456 (2%) | 0% | 2.8 | 6,024 | Common Stock | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.,&Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 170,000 | 170,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Onsi Douglas E. | Director, CEO,CFO,Pres.,GC,Treas.,&Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 170,000 | 170,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Onsi E. Douglas | Director, CEO,CFO,Pres.,GC,Treas.,&Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 7,500 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Onsi E. Douglas | Director, CEO,CFO,Pres.,GC,Treas.,&Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2024 | 7,500 | 73,646 (0%) | 0% | - | Common Stock | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.,&Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 140,000 | 140,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.,&Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 750,000 | 750,000 | - | - | Employee Stock Option (Right to Buy) | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.,&Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2023 | 660,606 | 661,466 (2%) | 2% | - | Common Stock | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.,&Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2023 | 660,606 | 0 | - | - | Restricted Stock Units | |
| Leap Therapeutics Inc | Douglas E. Onsi | Director, CEO,CFO,Pres.,GC,Treas.,&Sec., Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 325,000 | 325,000 | - | - | Restricted Stock Units |